Search
for
Sort by
Research 31–60 of 714
- 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation
- Equine 5α-reductase activity and expression in epididymis
- Case report: pemphigus vulgaris in an adolescent
- A New Era of 5α-Reductase Inhibitors for Androgenetic Alopecia
- Faculty Opinions recommendation of Platelet-Rich Plasma and Its Utilities in Alopecia: A Systematic Review.
- Reflectance confocal microscopy assessment of alopecia: A case report
- Commentary
- Diazepam-Induced Amnesia for Cardioversion
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Leave the Fat, Skip the Bolster: Thinking outside the Box in Lower Third Nasal Reconstruction
- In Vitro Main Pathways of Steroid Action in Cultured Hair Follicle Cells: Vascular Approach
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Can chronic recurrent dermatoses be managed through augmented virtual reality?
- An Investigation Into the Frequency of Use of Traditional and Complementary Medicine in Patients Presenting to the Dermatology Clinic: A Survey Study
- Attenuation of 5α-reductase-mediated progesterone metabolism promotes differentiation of human endometrial stromal cells for the establishment of pregnancy
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Book Reviews
- Ingredients Present In Personal Care Products That Need Scrutiny
- The role of androgen and androgen receptor in skin-related disorders
- Structure of human type II 5 alpha-reductase gene.
- Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Prevention of doxorubicin-induced alopedia by scalp hypothermia: relation to degree of cooling.
- Psychodermatology
- Alopecia and Mood Stabilizer Therapy
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men